JP2018531016A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018531016A5 JP2018531016A5 JP2018519323A JP2018519323A JP2018531016A5 JP 2018531016 A5 JP2018531016 A5 JP 2018531016A5 JP 2018519323 A JP2018519323 A JP 2018519323A JP 2018519323 A JP2018519323 A JP 2018519323A JP 2018531016 A5 JP2018531016 A5 JP 2018531016A5
- Authority
- JP
- Japan
- Prior art keywords
- transduced
- cell
- nucleic acid
- acid sequence
- cxcr6
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021162481A JP2022008805A (ja) | 2015-10-16 | 2021-10-01 | 腫瘍標的療法のためのｃｘｃｒ６形質導入ｔ細胞 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15190179 | 2015-10-16 | ||
| EP15190179.0 | 2015-10-16 | ||
| PCT/EP2016/074644 WO2017064222A1 (en) | 2015-10-16 | 2016-10-14 | Cxcr6-transduced t cells for targeted tumor therapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021162481A Division JP2022008805A (ja) | 2015-10-16 | 2021-10-01 | 腫瘍標的療法のためのｃｘｃｒ６形質導入ｔ細胞 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2018531016A JP2018531016A (ja) | 2018-10-25 |
| JP2018531016A6 JP2018531016A6 (ja) | 2018-12-13 |
| JP2018531016A5 true JP2018531016A5 (enExample) | 2019-11-28 |
| JP7018387B2 JP7018387B2 (ja) | 2022-02-10 |
Family
ID=54359823
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018519323A Active JP7018387B2 (ja) | 2015-10-16 | 2016-10-14 | 腫瘍標的療法のためのｃｘｃｒ６形質導入ｔ細胞 |
| JP2021162481A Pending JP2022008805A (ja) | 2015-10-16 | 2021-10-01 | 腫瘍標的療法のためのｃｘｃｒ６形質導入ｔ細胞 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021162481A Pending JP2022008805A (ja) | 2015-10-16 | 2021-10-01 | 腫瘍標的療法のためのｃｘｃｒ６形質導入ｔ細胞 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11723922B2 (enExample) |
| EP (1) | EP3362569B1 (enExample) |
| JP (2) | JP7018387B2 (enExample) |
| AU (2) | AU2016336868B2 (enExample) |
| CA (1) | CA3001507C (enExample) |
| DK (1) | DK3362569T3 (enExample) |
| ES (1) | ES2895901T3 (enExample) |
| WO (1) | WO2017064222A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018152572A1 (en) * | 2017-02-21 | 2018-08-30 | The University Of Adelaide | T cells expressing chemokine receptors for treating cancer |
| BR112019020909A2 (pt) | 2017-04-05 | 2020-05-12 | Korea Research Institute Of Bioscience And Biotechnology | Proteína de fusão ativadora de célula nk, célula nk e composição farmacêutica incluindo a mesma |
| US20210002609A1 (en) * | 2017-12-05 | 2021-01-07 | Caribou Biosciences, Inc. | Modified lymphocytes |
| US20210130438A1 (en) * | 2019-10-28 | 2021-05-06 | The Broad Institute, Inc. | Pan-cancer t cell exhaustion genes |
| CN116333984A (zh) * | 2020-07-14 | 2023-06-27 | 广州泛恩生物科技有限公司 | 基于galnt2阳性t细胞的用于杀伤肿瘤的tcr-t细胞及其制备方法和应用 |
| CN113736740A (zh) * | 2021-07-27 | 2021-12-03 | 天津市肿瘤医院（天津医科大学肿瘤医院） | 胰腺癌稳转细胞系及其构建方法和应用 |
| WO2023158997A2 (en) * | 2022-02-15 | 2023-08-24 | Memorial Sloan-Kettering Cancer Center | Compositions including killer innate-like t cells and uses therof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6696244B2 (en) * | 1997-07-17 | 2004-02-24 | New York University | G-coupled receptors associated with retroviral entry into cells, and therapeutic uses thereof |
| DE19822115B4 (de) | 1998-05-08 | 2004-04-08 | Heinrich-Pette-Institut | Retrovirale Gentransfervektoren |
| CN101287831B (zh) | 2005-09-13 | 2013-05-15 | 国立大学法人三重大学 | T细胞受体和编码该受体的核酸 |
| WO2010012829A1 (en) | 2008-07-31 | 2010-02-04 | Helmholtz Zentrum München Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh) | Her2/neu specific t cell receptors |
| PH12013501201A1 (en) | 2010-12-09 | 2013-07-29 | Univ Pennsylvania | Use of chimeric antigen receptor-modified t cells to treat cancer |
| TR201815488T4 (tr) | 2011-04-08 | 2018-11-21 | Health | Anti-epidermal büyüme faktör reseptörü varyant III kimerik antijen reseptörleri ve kanser tedavisi için kullanımı. |
| IN2014CN02906A (enExample) | 2011-10-20 | 2015-07-03 | Us Health | |
| CA2868121C (en) | 2012-03-23 | 2021-06-01 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-mesothelin chimeric antigen receptors |
| ES3065694T3 (en) | 2012-04-11 | 2026-05-07 | Us Health | Chimeric antigen receptors targeting b-cell maturation antigen |
| US9657105B2 (en) | 2013-03-15 | 2017-05-23 | City Of Hope | CD123-specific chimeric antigen receptor redirected T cells and methods of their use |
| TWI654206B (zh) | 2013-03-16 | 2019-03-21 | 諾華公司 | 使用人類化抗－ｃｄ１９嵌合抗原受體治療癌症 |
| JP6285553B2 (ja) | 2013-08-26 | 2018-02-28 | インノバイオファーム リミテッド | 抗ｃｄ３０キメラ抗原受容体およびその使用 |
-
2016
- 2016-10-14 JP JP2018519323A patent/JP7018387B2/ja active Active
- 2016-10-14 US US15/768,301 patent/US11723922B2/en active Active
- 2016-10-14 CA CA3001507A patent/CA3001507C/en active Active
- 2016-10-14 AU AU2016336868A patent/AU2016336868B2/en active Active
- 2016-10-14 DK DK16793764.8T patent/DK3362569T3/da active
- 2016-10-14 ES ES16793764T patent/ES2895901T3/es active Active
- 2016-10-14 EP EP16793764.8A patent/EP3362569B1/en active Active
- 2016-10-14 WO PCT/EP2016/074644 patent/WO2017064222A1/en not_active Ceased
-
2021
- 2021-10-01 JP JP2021162481A patent/JP2022008805A/ja active Pending
-
2022
- 2022-07-14 AU AU2022205240A patent/AU2022205240A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7755890B2 (ja) | Ｃａｒ発現ベクター及びｃａｒ発現ｔ細胞 | |
| Rezvani et al. | Engineering natural killer cells for cancer immunotherapy | |
| Bailey et al. | Gene editing for immune cell therapies | |
| Sangiolo | Cytokine induced killer cells as promising immunotherapy for solid tumors | |
| IL259120A (en) | Her2-targeted antigen chimeric receptors2 | |
| JP6899333B2 (ja) | 汎用キラーｔ細胞 | |
| JP2017533706A5 (enExample) | ||
| JP2019523001A5 (enExample) | ||
| FI3102609T3 (fi) | Menetelmiä b-solukasvaimien ja muiden syöpien hoidossa käyttökelpoisten autologisten t-solujen ja niiden koostumusten valmistamiseksi | |
| WO2019222275A3 (en) | Compositions and methods for tcr reprogramming using inducible fusion proteins | |
| JP2017515506A5 (enExample) | ||
| JP2019500894A5 (enExample) | ||
| RU2022103870A (ru) | Модифицированный иммунорегуляторный элемент и изменение иммунитета посредством этого элемента | |
| BR112019020001A2 (pt) | linhagens celulares estimuladoras para expansão ex vivo e ativação de células exterminadoras naturais | |
| JP2016539929A5 (enExample) | ||
| IL292650B1 (en) | COSTIMULATORY CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING IL13Ra2 | |
| JP2018522072A5 (enExample) | ||
| RU2015143513A (ru) | Микровезикула и способ ее получения | |
| CN102559600A (zh) | 一种人工抗原递呈细胞及其在nk细胞扩增中的应用 | |
| JP2017533707A5 (enExample) | ||
| JP2022519704A5 (enExample) | ||
| CN105802909B (zh) | 具有her2特异性tcr的t细胞制备物及其用途 | |
| Van Caeneghem et al. | Antigen receptor-redirected T cells derived from hematopoietic precursor cells lack expression of the endogenous TCR/CD3 receptor and exhibit specific antitumor capacities | |
| JP2022512538A5 (enExample) | ||
| TW202102667A (zh) | 用於擴增和分化供過繼性細胞治療之ｔ淋巴細胞和天然殺手（ｎｋ）細胞之方法 |